Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Bonanno

Showing results (31-40 of 126) with videos related to

Pageof 13
Sort By:
International Journal of Molecular Sciences|April 19, 2019
LKB1 and Tumor Metabolism: The Interplay of Immune and Angiogenic Microenvironment in Lung CancerLaura Bonanno, Elisabetta Zulato, Alberto Pavan, et al.
Critical Reviews in Oncology/Hematology|February 21, 2024
The study of primary and acquired resistance to first-line osimertinib to improve the outcome of EGFR-mutated advanced Non-small cell lung cancer patients: the challenge is open for new therapeutic strategiesAlessandra Ferro, Gian Marco Marinato, Cristiana Mulargiu, et al.
Cancers|May 28, 2020
Novel Nuclear Medicine Imaging Applications in Immuno-OncologyStefano Frega, Alessandro Dal Maso, Giulia Pasello, et al.
Cancer Treatment Reviews|May 26, 2024
The emerging role of Schlafen-11 (SLFN11) in predicting response to anticancer treatments: Focus on small cell lung cancerDaniela Scattolin, Alessandro Dal Maso, Alessandra Ferro, et al.
Cancer Treatment Reviews|May 24, 2020
Real world data in the era of Immune Checkpoint Inhibitors (ICIs): Increasing evidence and future applications in lung cancerGiulia Pasello, Alberto Pavan, Ilaria Attili, et al.
Critical Reviews in Oncology/Hematology|June 4, 2021
Treatment strategies for locally advanced non-small cell lung cancer in elderly patients: Translating scientific evidence into clinical practiceLaura Bonanno, Ilaria Attili, Alberto Pavan, et al.
Frontiers in Oncology|March 26, 2024
Efficacy of osimertinib and the role of sequential liquid biopsy in patients diagnosed with NSCLC harboring EGFR and BRAF mutations at baseline: insights from two case reportsLoc Carlo Bao, Alessia Padovan, Andrea Boscolo Bragadin, et al.
Frontiers in Medicine|June 28, 2021
Subacute Cutaneous Lupus Erythematosus-Like Eruption Induced by EGFR -Tyrosine Kinase Inhibitor in <i>EGFR</i>-Mutated Non-small Cell Lung Cancer: A Case ReportAlessandra Ferro, Angela Filoni, Alberto Pavan, et al.
Anticancer Research|December 11, 2012
Pemetrexed plus carboplatin or cisplatin as neoadjuvant treatment of operable malignant pleural mesothelioma (MPM)Giulia Pasello, Giuseppe Marulli, Valentina Polo, et al.
Cancer Biology & Therapy|June 6, 2015
Braf mutation in interdigitating dendritic cell sarcoma: a case report and review of the literatureElisabetta Di Liso, Natale Pennelli, Gigliola Lodovichetti, et al.
Pageof 13

Showing results (31-40 of 126) with videos related to

Sort By:
Pageof 13
International Journal of Molecular Sciences|April 19, 2019
LKB1 and Tumor Metabolism: The Interplay of Immune and Angiogenic Microenvironment in Lung CancerLaura Bonanno, Elisabetta Zulato, Alberto Pavan, et al.
Critical Reviews in Oncology/Hematology|February 21, 2024
The study of primary and acquired resistance to first-line osimertinib to improve the outcome of EGFR-mutated advanced Non-small cell lung cancer patients: the challenge is open for new therapeutic strategiesAlessandra Ferro, Gian Marco Marinato, Cristiana Mulargiu, et al.
Cancers|May 28, 2020
Novel Nuclear Medicine Imaging Applications in Immuno-OncologyStefano Frega, Alessandro Dal Maso, Giulia Pasello, et al.
Cancer Treatment Reviews|May 26, 2024
The emerging role of Schlafen-11 (SLFN11) in predicting response to anticancer treatments: Focus on small cell lung cancerDaniela Scattolin, Alessandro Dal Maso, Alessandra Ferro, et al.
Cancer Treatment Reviews|May 24, 2020
Real world data in the era of Immune Checkpoint Inhibitors (ICIs): Increasing evidence and future applications in lung cancerGiulia Pasello, Alberto Pavan, Ilaria Attili, et al.
Critical Reviews in Oncology/Hematology|June 4, 2021
Treatment strategies for locally advanced non-small cell lung cancer in elderly patients: Translating scientific evidence into clinical practiceLaura Bonanno, Ilaria Attili, Alberto Pavan, et al.
Frontiers in Oncology|March 26, 2024
Efficacy of osimertinib and the role of sequential liquid biopsy in patients diagnosed with NSCLC harboring EGFR and BRAF mutations at baseline: insights from two case reportsLoc Carlo Bao, Alessia Padovan, Andrea Boscolo Bragadin, et al.
Frontiers in Medicine|June 28, 2021
Subacute Cutaneous Lupus Erythematosus-Like Eruption Induced by EGFR -Tyrosine Kinase Inhibitor in <i>EGFR</i>-Mutated Non-small Cell Lung Cancer: A Case ReportAlessandra Ferro, Angela Filoni, Alberto Pavan, et al.
Anticancer Research|December 11, 2012
Pemetrexed plus carboplatin or cisplatin as neoadjuvant treatment of operable malignant pleural mesothelioma (MPM)Giulia Pasello, Giuseppe Marulli, Valentina Polo, et al.
Cancer Biology & Therapy|June 6, 2015
Braf mutation in interdigitating dendritic cell sarcoma: a case report and review of the literatureElisabetta Di Liso, Natale Pennelli, Gigliola Lodovichetti, et al.
Pageof 13